Preliminary programme
Please, note that the Conference agenda may still undergo changes due to organizational reasons.
LAST UPDATE: 03.11.2026
SESSION 3
THE CHANGING LANDSCAPE OF HEMOPHILIA THERAPY: FROM INNOVATION TO CLINICAL PRACTICE
9:00-9:15
Mimetic approaches: from mechanisms to clinical monitoring and the future
9:15-9:30
Non-replacement therapies: the evolution of targeted approaches
9:30-9:45
Next-generation CAR-T cell therapy for acquired hemophilia A
9:45-10:00
Discussion
Oral Communications
10:00-11:00
TBD
11:00-11:30
Coffee break
SESSION 4
11:30-11:40
Accessibility to patients of all available novel drugs
11:40-11:50
Affordability
11:50-12:00
Patient preferences
12:00-12:15
Discussion
SATELLITE SYMPOSIUM
12:15-13:15
BOOKED
13:15-14:15
Lunch
SATELLITE LECTURE
14:15-14:45
BOOKED
SATELLITE LECTURE
14:45-15:15
BOOKED
PENDING SESSION
15:15-15:45
TBD
15:45-16:15
Coffee break
SESSION 5
NEW therapies for VWD
16:15-16:30
Can we bypass VWF by targeting thrombin generation in VWD?
16:30-16:45
Gene editing for VWD
16:45-17:00
Inhibiting ADAMTS-13 to treat device-associated acquired von Willebrand syndrome
17:00-17:15
Discussion
E-Posters
17:15-18:15
TBD